Veravas, Inc. products

Detect HAMA, heterophilic and biotin interferences in one easy test. While it is known that interferences in lab samples are common,¹ the threat to patients is often underestimated. Of the 100 million lab tests that are incorrect each year due to sample interferences, 50% lead to wrong diagnoses, resulting in 16 million unnecessary treatments per year.² Worse yet, but unmeasurable, is the implication of missed diagnoses resulting in delayed treatment and disease progression. Still, it has been difficult to address the issue of sample interferences until now. Veravas has created a unique sample screening system that uses magnetic particle (nanobead) technology and magnetic separation to detect the most common immunoassay interferences, including HAMA, heterophilic and free biotin interferences.